logo

A primary study on biological behavior of aluminum using 26Al-AMS

NUCLEAR PHYSICS AND INTERDISCIPLINARY RESEARCH

A primary study on biological behavior of aluminum using 26Al-AMS

Song-Mei Qin
Xiang-Gao Wang
Xiao-Xi Lan
Yun-Ting Gu
Ke-Jun Dong
Ming He
Shan Jiang
Nuclear Science and TechniquesVol.27, No.3Article number 53Published in print 20 Jun 2016Available online 06 May 2016
50901

Aluminum is concerned as a possible cause of many diseases. To investigate the long-term Al biokinetics and bioavailability in various kinds of Al-contained medicine and food, an accelerator mass spectrometry (AMS) based on the HI-13 tandem has been established for biological analysis with 26Al (T1/2= 716 000 yr) as the tracer. In this paper, the animal tracing, sample preparation procedure and 26Al-AMS measurement are presented. The sample preparation procedure has been simplified. A high sensitivity of 5×10−15 for 26Al/27Al has been achieved. Two phases were found before and after a break time (tb) for the 26Al retained in blood and brain, with tb ≈ 8 and 12 hours after the 26Al tracer injection, respectively.

26AlAccelerator mass spectrometryBiological tracing

1. Introduction

Aluminum is the most abundant metal element in the environment, and is the most common metal element in our life. It is also a trace element in human body, but not the essential one. In medicine, chemical Al-compounds are used as antiseptic, alum, antacid or phosphate binder for dialysis patients with renal failure. On the other hand, Al is concerned as a cause of many diseases (e.g. osteopathy, anemia and encephalopathy)[1-5], if its intake is too much.

As shown in Table 1, neither of the radioisotopes is suitable for use as an tracer to study Al biological behavior and bioavailability in animals and human, which had been carried out by employing just the stable isotope 27Al[3] before 1990. Since the natural level of 27Al in the environment (~ 0.1g/g) is far greater than that in biological samples (10−6–10−8g/g), the research on behaviors of Al in animals and human had been obstructed by difficulties in distinguishing the trace amount of Al in biological samples from the environment.

Table 1
The information of isotopes of aluminum
Isotopes 25Al 26Al 27Al 28Al 29Al
T1/2 7.2 s 716,000 yr Stable 2.3 min 6.6 min
Show more

Therefore, two tracer approaches are well accepted to study Al biokinetics. One is the use of congeners, such as radioactive 67Ga, based on similar chemical properties of Al and Ga. However, their chemical reactions in body are different [6,7]. Another one is the accelerator mass spectrometry (AMS)[8-13], or ultra-sensitivity mass spectrometry, using 26Al, the only long-life radioisotope of Al (T1/2=716,000 yr), and the only Al isotope being capable of tracing research, but quite difficult, though. The methods for measuring 26Al include decay counting and conventional mass spectrometry (MS). MS cannot discriminate 26Al from the 26Mg isobar, while the decay counting method to detect the trace amount of 26Al (close to detection limits) is of large uncertainties. Therefore, 26Al tracer in medical application is very difficult without AMS, which is advantages over MS methods in its high sensitivity, small sample size requirement, free from isobar and molecular ion interferences, and short measurement time.

Taking advantages of nomeasurable 26Al in the environment or in normal biological organisms, the 26Al-AMS approach, which avoids interference of endogenous Al in studying Al biokinetic and bioavailability, has been carried out in several groups [2,3,14-25]. Studies with26Al-AMS on mice aluminum biokinetic were performed by the groups in Manchester[3,15,16], Orsay[17], Zurich[18], Tokyo[19], Munich-Aachen[2], and Kentucky [20]. The Manchester and Munich-Aachen groups did studies on human Al biokinetic, too. They found that some Al is retained in the body, most probably within the skeleton and brain. Most of Al that enters the blood is excreted in urine within a few days or weeks. Al bioavailability was estimated in a number of 26Al-AMS studies, including a model food and biscuit containing acidic SALP[20-24]. It was also found that typical human foods have high Al bioavailability, but still, there are Al-contained medicine and food with unknown Al biokinetic and bioavailability. Too much human intake of Al may be retained in skeleton and brain, which may cause osteopathy, anemia and encephalopathy.

We need 26Al-AMS to investigate the long-term Al biokinetics and bioavailability in Al-contained medicine and food in China. In this paper, a 26Al-AMS tracing method is established and the primary results are presented.

2. Materials and methods

2.1 Animals

Wistar rats of 2-months old were purchased from Guangxi Medical University, Nanning, China, and fed with standard diet. All animal experiments were performed according to the Guidelines for the Care and Use of Laboratory Animals [26]. The mice were divided into the experimental, control and background groups, with 3 mice in each group. The tracer isotope 26Al is the laboratory standard kept from 1996 at the AMS lab of China Institute of Atomic Energy (CIAE) AMS. Decay counting method was used to calibrate the 26Al/27Al ratio. The 26Al/27Al ratio of AlCl3 solution for injection was 1.5×10−9, with the 26Al content of 2.5 μg/mL. The solution was prepared by successive dilution of the original standard sample. The three animal groups were treated as follows:

1) Experimental group: The mice are used to inject 26Al for experimental tracing. 30 mice were divided into 10 subgroups (n =3) for 10 time scales. The mice were tail mainline injected with 1 mL of 26AlCl3 (pH=4.5), and were blood-sampled and euthanized for brain-sampling at 0.5, 2, 4, 8, 16, 48, 72, 96, 120 and 168 h after injection.

2) Control group (n =3): The mice were injected with 1 mL 27AlCl3 solution, for the behavior observation.

3) Background group (n =3): The mice were injected with 1mL normal saline solution for AMS measurement of the 26Al as background sample.

2.2 Sample preparation

The beam current of 26AlO is 20–40 times higher than the 26Al, but the number of 26Mg isobar will become too large to identify 26Al of ultra-low level. Besides, the particle transmission of single atom is higher than molecular ions. Therefore, a single atomic negative Al form is adopted in our AMS measurement. Taking advantage of the electric potential of Mg electron affinity is lower than zero, Mg- ions cannot be extracted, but the Al- can, from the AMS multi-cathode source. As the interfere isobar 26Mg is no longer a problem, a simplified preparation process was developed (Fig. 1).

Fig. 1.
The sample preparation procedure.
pic

1) The blood/brain samples were decomposed with 10 mL of concentrated nitric acid at 80°C for 24 h in a Teflon-sealed vessel

2) After cooling, 15 mg of 27AlCl3 were added in the sample solution as a carrier, and then heat at 140°C for 4 h in a Teflon-sealed vessel inserted in a stainless steel botter.

3) After cooling, the blood samples were centrifuged and Al-contained solution samples will be obtained.

4) Add NaOH solution to the Al-containing sample solution, and carefully adjust the solution to PH7–8. Al(OH)3 sediment can be formed at pH=7–8, while a very few of Mg(OH)2 can be formed at this pH value. Therefore, the most of 26Mg, isobar of our interesting isotope 26Al, could be eliminated in this step.

5) Al(OH)3 sediment was obtained via centrifugation, and then converted to Al2O3 at 1000°C for 2h.

In the AMS measurement, each sample was mixed with an equal mass of pure silver powder for improving thermal and electric conductivity, and pressed into a sample holder of a 40-sample NEC MC-SNICS ion source.

2.3 Analysis of 26Al by accelerator mass spectrometry

The number of 26Al was measured with the AMS at CIAE (Fig.2). Since its installation in 1989, 26Al, 36Cl, 41Ca, 55Fe, 64Gu, 79Se, 99Tc, 129I,151Sm, 182Hf, 236U and 237Np have been measured for applications in biomedicine, nuclear physics, nuclear astrophysics and environmental science [11,27-36]. Fig. 2 shows schematically the AMS system based on an HI-13 Tandem accelerator. This work was carried out on AMS Beamline 1. The AMS Beamline 2 was for AMS research of medium-heavy mass nuclides..

Fig. 2.
Schematic diagram of the accelerator mass spectrometer based on the HI-13 tandem accelerator at CIAE.
pic

Single atomic ions of Al from the ion source are selected by the low energy magnetic analysis system for injection into HI-13Tandem accelerator, typically with 40 nA beam current at the lower energy Faraday cup (LEFC). The Al ions are pre-accelerated to 110 keV in the low energy system, and to 7 MeV by the first column of the tandem accelerator. The negative ions are stripped by a 3 μg/cm2 thick carbon foil, and the position ions are further accelerated in the second column by the terminal voltage. A 90° double-focusing analyzing magnet was used to select ions 26Al7+, with energy of 56.1 MeV. According to theoretical simulation of the charge stripping, the charge state 7+ at 7 MV has a large fraction of ~34%. The 26Al7+ ion beams are transported to the AMS Beamline 1 and detection system, with a switching magnet and 15° electrostatic deflector. The analyzer magnet, switching magnet, electrostatic analyzer and other beam optical elements are adjusted to obtain optimal 26Al7+ beam line.

Since no interference of 26Mg isobar, a Si(Au) surface barrier detector is used to record the number and energy of the 26Al7+. The 27Al beam current is record by the LEFC in low energy system, and the 26Al/27Al isotope ratios can be obtained. In this study, each sample was measured at least three times. All isotope ratios were normalized by 26Al/27Al standards sample.

3. Results

3.1 26Al-AMS based on extracting Al- ions

Typically, the beam current of 27Al is ~40 nA at LEFC. The ions extracting is stable (Fig.3), which is crucial for measurement precision. Typical current is lower than that at UTTAC and SUERC[37,38], because of mainly the low electron affinity of Al, and the not-so-good ion source and low energy system, caused by a low vacuum problem at that time. However, this did not have much effect on this work.

Fig. 3.
Beam currents of 27Al−- of the commercial Al2O3 sample and biological Al2O3 sample prepared at our AMS lab..
pic

The preparation of biological sample is a key step in the tracing experiment. As shown Fig. 3, beam current of the prepared Al2O3 sample is over 40 nA, and it is larger than that of commercial sample. The overall particle transmission between the low energy injection system and the detection system is ~3%. Fig .4(a) is the 56.1 MeV 26Al7+ ion spectra of the background sample prepared with the same sample preparation procedure. It demonstrates that there were no interference isotopes in our measurement. The combination of our sample preparation procedure and extraction of single atomic negative Al from the ion source, the 26Mg isobar is highly suppressed. Fig. 4(b) is spectra of the blood sample, and it can be sure that the peak at 56.1 MeV is the counts of 26Al7+ ions. The simplicity preparation procedure can satisfy the biological tracing requirement.

Fig. 4.
Spectra of 56.1 MeV 26Al7+ ions, detected by a Si(Au) surface barrier detector.
pic

We used the blank sample (commercial Al2O3 and our background sample) to test the AMS system. The sensitivity is good, with the 26Al/27Al ratio of lower than 5×10−15.

3.2 Al biological behavior in blood

In this work to establish the 26Al-AMS method for biological tracing, the 26Al/27Al ratio, instead of the 26Al concentration, is used. The 26Al concentration can be got from 26Al = (26Al/27Al) ratio×27Al concentration, which can be measured by spectrophotometry.

The data of 26Al/27Al ratios in blood are shown in Fig.5. Because of limit in beam time of the tandem accelerator, we measured the blood samples of six time points (0.5, 2, 8, 16, 48, 168 h). The data could be fitted with a nonlinear function:

Fig. 5
Biological behavior of 26Al/27Al in blood. The data, were fitted by a nonlinear function and a two-component function (tb,≈8 h).
pic
26Al/27Al=1.63×1010t(1.588±0.355).

The decrease index is similar with the result of Priest et al.[3], who found that the Al concentration (AAl) in the blood after injection varied in a function of time as AAl = 0.206 t −1.250.

We also found, as shown in Fig. 5, that the data also can be well fitted by a two-component function of time,

26Al/27Al=1.85×1011[(t/tb)(0.457±0.121)+ (t/tb)(2.921±0.195)],

where the tb≈8 h is break time, and the exponents −(0.457±0.121) and −(2.921±0.195) denote respectively the time before and after tb,, corresponding to the slow and fast decrease phase.

3.3 Al biological behavior in brain

Brain samples of five time points (2,16,48,72 and 168 h) were measured. The 26Al/27Al results are shown in Fig. 6. It can be seen that the brain 26Al/27Al ratio went up quickly in 16 h after the Al injection. It retained stable in the first week, with a nonlinear function of 26Al / 27Al =1.41×10−13 t −(0.142±0.136) .

Fig. 6
Biological behavior of 26Al/27Al in brain. The data were fitted by a nonlinear function and a two-component function (tb,≈12 h).
pic

Also, the data could be well fitted by a two-component function of time, as shown in Fig.6,

26Al/27Al=1.10×1013[(t/tb)(1.620±0.125)+ (t/tb)(0.142±0.136]  ,

where the tb≈12 h is the break time. The Al content in brain increased before tb with an increase index of 1.620±0.125,corresponding to the slow decrease phase of the blood sample (Fig.5). After the Al came into the brain, it would decrease slowly, with a decrease index of −(0.142±0.136). If the Al intake continues, the Al accumulated in brain would cause many kinds of diseases.

4. Conclusion

In conclusion, a 26Al-AMS tracing method including the animal tracing, sample preparation and AMS measurement have been established on the HI-13 tandem accelerator. The sample preparation procedure is simplified, and easy to achieve. By extracted single atomic negative Al-from ion source, taking advantage of the lack of any isobaric interference, a high sensitivity of lower than 5×10-15 for 26Al/27Al has been achieved.

We found that the 26Al/27Al ratio in blood and brain behaved as a two-component function of time. The blood 6Al/27Al ratios show a low and a fast decrease phase before and after a break time tb (about 8 hours post injection), with a decrease index −(0.457±0.121) and −(2.921±0.195), respectively. These two phases are related to the fast increase and slow decrease phase in the brain6Al/27Al ratios, before and after a time tb time (about 12 hours post injection), with the index (1.620±0.125)and −(0.142±0.136). After the time tb, the Al in the brain decreased very slowly. If the Al intake continues, the Al accumulation in the brain will cause many kinds of diseases.

Further experiments are needed to prove the Al biological behavior.

References
[1] A. C. Alfrey, G. R. LeGendre, W. D. Kaehny,

The dialysis encephalopathy syndrome — possible aluminum intoxication

. N Engl J Med, 294:184-188 (1976). DOI: 10.1056/NEJM197601222940402
Baidu ScholarGoogle Scholar
[2] Ch. Hohl, P. Gerisch, G. Korschinek et al.,

Medical application of 26Al

. Nucl Instrum Meth B, 92:478-482 (1994). DOI: 10.1016/0168-583X(94)96058-5
Baidu ScholarGoogle Scholar
[3] N. D. Priest,

The biological behaviour and bioavailability of aluminium in man, with special reference to studies employing aluminium-26 as a tracer: review and study update

, J Environ Monitor, 6:375-403 (2004). DOI: 10.1039/B314329P
Baidu ScholarGoogle Scholar
[4] M. Kawahara,

Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases

, J Alzheimers Dis, 8:171-182 (2005).
Baidu ScholarGoogle Scholar
[5] WHO,

Backgrounddocumentfordevelopmentof WHO Guidelines forDrinking-water Quality (4th edition)

, http://www.who.int/water_sanitation_health/publications/dwq_guidelines/en/.
Baidu ScholarGoogle Scholar
[6] N. D. Priest, D. Newton, J. P. Day et al.,

Human metabolism of aluminium-26 and gallium-67 injected as citrates

. Hum Exp Toxicol, 14:287-293 (1995). DOI: 10.1177/096032719501400309
Baidu ScholarGoogle Scholar
[7] C. B. Dobson, J. P. Day, S. J. King et al.,

Location of aluminium and gallium in human neuroblastoma cells treated with metal-chelating agent complexes

.Toxicol Appl Pharm, 152:145-152 (1998). DOI: 10.1006/taap.1998.8489
Baidu ScholarGoogle Scholar
[8] L. W. Alvarez, R. Cornog,

He3 in helium

. Phys Rev, 56: 379-379(1939). DOI: 10.1103/PhysRev.56.379.2
Baidu ScholarGoogle Scholar
[9] E. D. Nelson, R. G. Korteling, W. R. Stott,

Carbon-14: direct detection at natural concentrations

. Science, 198: 507-508 (1977). DOI: 10.1126/science.198.4316.507
Baidu ScholarGoogle Scholar
[10] C. L. Bennett, R. P. Beukens, M. R. Clover et al.,

Radiocarbon dating using electrostatic accelerators: negative ions provide the key

. Science, 198:508-510 (1977). DOI: 10.1126/science.198.4316.508
Baidu ScholarGoogle Scholar
[11] S. Jiang, M. He, S. S. Jiang et al.,

Development of AMS measurements and applications at the CIAE

. Nucl Instrum Meth B, 172:87-90 (2000). DOI: 10.1016/S0168-583X(00)00370-0
Baidu ScholarGoogle Scholar
[12] C. D. Shen, W. X. Yi, K. F. Yu et al.,

Holocene megathermal abrupt environmental changes derived from 14C dating of a coral reef at Leizhou Peninsula, South China Sea

.Nucl Instrum Meth B,B223-224: 416-419 (2004). DOI: 10.1016/j.nimb.2004.04.079
Baidu ScholarGoogle Scholar
[13] L. Liu, W. J. Zhou, P. Cheng et al.,

A new dual injection system for AMS facility

. Nucl Instrum Meth B, 259:208-212 (2007). DOI: 10.1016/j.nimb.2007.01.160
Baidu ScholarGoogle Scholar
[14] S. L. Wang, Y. H. Liu, D. M. Li et al.,

Study of 26Al measurement on the Shanghai Mini-cyclotron based AMS

. Nucl Instrum Meth B, 266:3302-3308 (2008). DOI: 10.1016/j.nimb.2008.04.007
Baidu ScholarGoogle Scholar
[15] J. P. Day, J. Barker, S. J. King et al.,

Biological chemistry of aluminium studied using 26Al and accelerator mass spectrometry

. Nucl Instrum Meth B, 92:463-468 (1994). Doi: 10.1016/0168-583X(94)96055-0
Baidu ScholarGoogle Scholar
[16] J. Barker, J. Templar S. J. King et al.,

AMS measurements to study uptake and distribution of 26Al in mice and the role of the transferrin receptor in aluminium absorption mechanisms

. Nucl Instrum Meth B, 123:275-278 (1997). DOI: 10.1016/S0168-583X(96)00704-5
Baidu ScholarGoogle Scholar
[17] P. Jouhanneau, G. M. Raisbeck, F. Yiou et al.,

Gastrointestinal absorption, tissue retention, and urinary excretion of dietary aluminum in rats determined by using 26Al

. Clin Chem, 43: 1023-1028 (1997).
Baidu ScholarGoogle Scholar
[18] K. W. Schonholzer, R. A. Sutton, V. R. Walker,

Intestinal absorption of trace amounts of aluminium in rats studied with 26aluminium and accelerator mass spectrometry

. Clin Sci, 92: 379-383 (1997).  DOI: 10.1042/cs0920379
Baidu ScholarGoogle Scholar
[19] S. Yumoto, H. Nagai, M. Imamura et al.,

26Al uptake and accumulation in the rat brain

. Nucl Instrum Meth B,123:279-282 (1997). DOI: 10.1016/S0168-583X(96)00429-6
Baidu ScholarGoogle Scholar
[20] B. H. Wang, G. S. Jackson, R. A. Yokel et al.,

Applying accelerator mass spectrometry for low-level detection of complex engineered nanoparticles in biological media

. J Pharm Biomed Anal, 294:39-42 (2014). DOI: 10.1016/j.jpba.2014.04.003
Baidu ScholarGoogle Scholar
[21] R. A. Yokel, R. L. Florence,

Aluminum bioavailability from tea infusion

. Food Chem Toxicol, 46: 3659-3663 (2008). DOI: 10.1016/j.fct.2008.09.041
Baidu ScholarGoogle Scholar
[22] Y. Z. Zhou, W. R. Harris, R. A. Yokel,

The influence of citrate, maltolate and fluoride on the gastrointestinal absorption of aluminum at a drinking water-relevant concentration: A 26Al and 14C study

. J Inorg Biochem, 102: 798-808 (2008). DOI: 10.1016/j.jinorgbio.2007.11.019
Baidu ScholarGoogle Scholar
[23] C. Steinhausena, G. Kislingera, C. Winklhofera et al.,

Investigation of the aluminium biokinetics in humans: a 26Al tracer study

. Food Chem Toxicol,  42:363-71 (2004). DOI: 10.1016/j.fct.2003.09.010
Baidu ScholarGoogle Scholar
[24] S. Yumoto, H. Nagai, S. Kakimi et al.,

26Al incorporation into the brain of rat fetuses through the placental barrier and subsequent metabolism in postnatal development

.Nucl Instrum Meth B, 268:1328-1330 (2010). DOI: 10.1016/j.nimb.2009.10.165
Baidu ScholarGoogle Scholar
[25] C. H. Guo, Y. F. Lu, G. S. Wang,

The influence of aluminum exposure on male reproduction and offspring in mice

. Environ Toxicol Phar, 20:135-141 (2005). DOI: 10.1016/j.etap.2004.11.007
Baidu ScholarGoogle Scholar
[26] National Research Council (US) Committee. Guide forthe Care and Useof Laboratory Animals (8th edition),Washington DC(USA): National Academies Press (US), 2011.
[27] M. He, S. Jiang, S. S. Jiang et al.,

Measurement of 79Se and 64Cu with PXAMS

. Nucl Instrum Meth B, 172:177-181 (2000). DOI: 10.1016/S0168-583X(00)00393-1
Baidu ScholarGoogle Scholar
[28] Y. J. Guang, M. He, X. D. Ruang et al.,

The development of a gas-filled time-of-flight detector

. Nucl Instrum Meth B,259:213-216 (2007). DOI: 10.1016/j.nimb.2007.01.310
Baidu ScholarGoogle Scholar
[29] K. J. Dong,M. He, S. Jiang et al.,

Measurement of trace 129I concentrations in CsI powder and organic liquid scintillator with accelerator mass spectrometry

. Nucl Instrum Meth B, 259:271-276 (2007). DOI: 10.1016/j.nimb.2007.01.232
Baidu ScholarGoogle Scholar
[30] X. G. Wang, S. Jiang, M. He et al.,

236U measurement with accelerator mass spectrometry at CIAE

. Nucl Instrum Meth B, 34:2295-2299 (2010). DOI: 10.1016/j.nimb.2010.03.017
Baidu ScholarGoogle Scholar
[31] X. G. Wang, S. Jiang, M. He et al.,

Accurate determination of cross-sections for 238U (n, 2n) 237U induced by neutrons around 14 MeV

. Nucl Instrum Meth A, 2010, 621:326-330. DOI: 10.1016/j.nima.2010.04.034
Baidu ScholarGoogle Scholar
[32] X. Y. Yin, M. He, K. J. Dong et al.,

Measurement of 151Sm with the HI-13 accelerator mass spectrometry system

. Nucl Instrum Meth B, 268:1689-1691 (2010). DOI: 10.1016/j.nimb.2010.02.126
Baidu ScholarGoogle Scholar
[33] X. G. Wang, S. Jiang, K. J. Dong et al.,

Development of laboratory standards for AMS measurement of 237Np

. Nucl Instrum Meth B, 268:1949-1953 (2010). DOI: 10.1016/j.nimb.2010.02.106
Baidu ScholarGoogle Scholar
[34] K. J. Dong, L. Y. Lu, M. He et al.,

Study on bone resorption behavior of osteoclast under drug effect using 41Ca tracing

. Nucl Instrum Meth B, 294:671-674 (2013). DOI: 10.1016/j.nimb.2012.08.051
Baidu ScholarGoogle Scholar
[35] S. Jiang, M. He, K. J. Dong et al.,

Large projects at the accelerator mass spectrometry facility at the China Institute of Atomic Energy during the last 12 years

. Nucl Instrum Meth B, 294:39-42 (2013). DOI: 10.1016/j.nimb.2012.02.011
Baidu ScholarGoogle Scholar
[36] X. G. Wang S. Jiang, M. He et al.,

Determination of cross sections for the 238U(n,3n)236U reaction induced by 14-MeV neutrons with accelerator mass spectrometry

. Phys. Rev. C, 87: 014612 (2013). DOI: 10.1103/PhysRevC.87.014612
Baidu ScholarGoogle Scholar
[37] K. Sasa, Y. Nagashima, T. Takahashi et al.,

26Al and 36Cl AMS system at the University of Tsukuba: A progress report

. Nucl Instrum Meth B, 259:41-46 (2007). DOI: 10.1016/j.nimb.2007.01.313
Baidu ScholarGoogle Scholar
[38] S. Xu, S. P. Freeman, D. H. Rood et al.,

Decadal 10Be, 26Al and 36Cl QA measurements on the SUERC 5 MV accelerator mass spectrometer

. Nucl Instrum Meth B, 361:39-42 (2015), DOI: 10.1016/j.nimb.2015.03.064
Baidu ScholarGoogle Scholar